ArticleCureus2026
An Atypical Presentation of a Non-neural Granular Cell Tumor.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-neural granular cell tumors (NNGCTs) represent a rare variant of granular cell tumors that lack S100 expression and do not demonstrate nerve-sheath differentiation, distinguishing them from conventional granular cell tumors (CGCTs), which are typically S100-positive and of Schwann cell origin. This report describes the case of a 46-year-old male presenting with a soft tissue mass arising from the right maxillary alveolar ridge. A hemimaxillectomy was performed, and the mass was sectioned to reveal light tan fibrous tissue grossly involving the underlying bone. The mass was composed of large neoplastic polygonal cells with granular cytoplasm that showed mild nuclear atypia and a low mitotic count. Immunohistochemical staining showed that the cells were positive for CD68 and CD45 expression but were negative for S100. The final diagnosis was reported as NNGCT. The prognosis, genetic alterations, and cellular origins of these tumors remain poorly understood. The findings included in this report will hopefully inform future investigations into the nature of NNGCTs and ultimately lead to improved treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.